Market Insight Drug Discovery |

Towards Degradable by Design Trifluoromethyl Groups

Stefan Schiesser

Stefan Schiesser

Director Of Medicinal Chemistry

AstraZeneca

12 August, 2026
Watch time: 23 Minutes

Highlights

Takeaways

- Trifluoromethyl groups have historically been key functional groups to optimize compound series in drug discovery

- However, their persistence in the environment has raised concerns about their impact on sustainability

- We show how we can finetune the stability of trifluoromethyl groups to be stable enough for medicinal chemistry while not persisting prolonged time in the environment

Stefan Schiesser, Director of Medicinal Chemistry, AstraZeneca

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.